SensArs Neuroprosthetics
PrivateLast Round
Grant
May 1, 2024
Total Funding Raised
$4.63M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
SensArs Neuroprosthetics operates in Healthcare & Life Sciences and is based in Lausanne. Its latest recorded funding round was a Grant round in May 2024.
SensArs Neuroprosthetics is a medical technology company that develops implantable neuroprosthetics to restore sensation for amputees and patients with nerve damage.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Clinical Trials, Sensors
Business Model
B2B2C
Customer Profile
Hardware Sales, Hardware + Subscription, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SensArs Neuroprosthetics Comparables
Compare SensArs Neuroprosthetics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MYNERVA AG | 76% | |
| Atom Limbs | 70% | |
| Integrum | 69% |
For institutional investors. Book with your work email.
SensArs Neuroprosthetics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 1, 2024 | ||||
| Pre Seed | May 1, 2024 | ||||
| Grant | May 1, 2024 | ||||
| Grant | Oct 8, 2019 | ||||
| Grant | Jul 3, 2017 | ||||
Accelerator | Feb 15, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
SensArs Neuroprosthetics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Union's Horizon Research and Innovation program | Grant |
| Eurostars SME programme | Grant |
| Venture Kick | Accelerator |
| Health Technology Holding | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Grew 38% QoQ, from 8 to 11 employees.
- Jan 8, 2026
Monthly visitors grew 730% MoM, from 197 to 1.6K.
For institutional investors. Book with your work email.
SensArs Neuroprosthetics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about SensArs Neuroprosthetics's valuation, stock price, and market status.
Is SensArs Neuroprosthetics a public or private company?
SensArs Neuroprosthetics is a private company.
What is the current stock price of SensArs Neuroprosthetics?
SensArs Neuroprosthetics is a private company, so its shares have no public market price. Caplight tracks SensArs Neuroprosthetics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is SensArs Neuroprosthetics worth (valuation)?
Valuation information for SensArs Neuroprosthetics is not publicly available.
Can I buy SensArs Neuroprosthetics stock?
SensArs Neuroprosthetics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was SensArs Neuroprosthetics's last funding round?
SensArs Neuroprosthetics's most recent funding round was Grant on May 1, 2024.
Who are the main investors in SensArs Neuroprosthetics?
Key investors in SensArs Neuroprosthetics include Health Technology Holding.
Will SensArs Neuroprosthetics IPO soon?
No public IPO plans have been announced for SensArs Neuroprosthetics.
How can I track SensArs Neuroprosthetics secondary market activity?
Caplight tracks bids, offers, and trades in SensArs Neuroprosthetics's shares on secondary markets.